Michael Parsons
Family Medicine · Palm Coast, FLNPI 1033169669
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $463 and has fallen 87.4% since, to $58 in 2025.
Across 55 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$173
- Smith+Nephew$156
- Amgen$141
- Aroa Biosurgery Incorporated$132
- Sanofi-aventis U.S. LLC$129
- Next Science LLC$101
- plus $581 from 17 others
What the payments were for
- Food & beverage$1,413100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 4 | $173 |
| Smith+Nephew | 2 | $156 |
| Amgen | 6 | $141 |
| Aroa Biosurgery Incorporated | 5 | $132 |
| Sanofi-aventis U.S. LLC | 7 | $129 |
| Next Science LLC | 1 | $101 |
| Tandem Diabetes Care, Inc. | 4 | $94 |
| UCB, Inc. | 3 | $57 |
| GSK | 3 | $55 |
| Medtronic | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Exact Sciences | 2 | $37 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Pfizer | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Insulet Corporation | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RENASYS TOUCH$132
- Kerendia$121
- Xperience$101
- BlastX$101
- SurgX$101
How this compares
$1,413 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 76 | $73,496 |
| Gentamicin Sulfate | 115 | $2,303 |
| Doxycycline Hyclate | 56 | $1,253 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $554 |
| Ciprofloxacin Hcl | 22 | $452 |
| Lisinopril | 23 | $401 |
| Fluticasone Propionate | 15 | $299 |
| Atorvastatin Calcium | 12 | $292 |
| Mupirocin | 11 | $175 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Palm Coast
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.